COMMUNIQUÉ DE PRESSE publié le 24/11/2020 à 13:00, il y a 5 années 11 mois Royal KPN N.V. Press Release: Members of Board of Management buy KPN shares
Publié le 10/11/2026 à 14:00, il y a 44 minutes Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 2 au 6 novembre 2026
Publié le 10/11/2026 à 14:00, il y a 44 minutes Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Publié le 10/11/2026 à 11:02, il y a 3 heures 41 minutes Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Publié le 10/11/2026 à 11:02, il y a 3 heures 41 minutes Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Publié le 10/11/2026 à 07:00, il y a 7 heures 44 minutes bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Publié le 10/11/2026 à 14:31, il y a 13 minutes First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Publié le 10/11/2026 à 14:30, il y a 14 minutes Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Publié le 10/11/2026 à 14:00, il y a 44 minutes Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Publié le 10/11/2026 à 14:00, il y a 44 minutes Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
Publié le 10/11/2026 à 14:35, il y a 9 minutes K-Beauty at CES: Kolmar Korea Becomes First Company to Win Best of Innovation in Beauty Tech Two Years in a Row
Publié le 10/11/2026 à 14:35, il y a 9 minutes XLIO Secures Additional $100 Million to Build Startups for Corporate Acquirers
Publié le 10/11/2026 à 14:31, il y a 13 minutes Knaus Tabbert more than doubles adjusted EBITDA in the first nine months of 2026
Publié le 10/11/2026 à 14:05, il y a 39 minutes Three Researchers Granted Over $1 Million to De-Risk and Progress Preclinical Drug Candidates for Neurodegenerative Diseases